TRENTON, NJ -- Despite the side effects reported impacting some young women who received the Johnson & Johnson COVID vaccine, Gov. Phil Murphy said that "no one who has received the J&J vaccine should panic or worry."  The governor tried to quell fears as the CDC and FDA called for a pause in the distribution of J&J vaccine "out of an abundance of caution."

Murphy said the review of the J&J vaccine is critical to New Jersey's efforts to ensure confidence in the state's vaccination program and the vaccines themselves.

"Yesterday, we decided to temporarily pause the administration of J&J’s vaccine upon the recommendation of CDC and FDA pending further investigation into six reported instances of severe blood clots," Murphy said. "In New Jersey, where we had administered just over 244,000 doses of the Johnson & Johnson vaccine prior to hitting pause, no similar adverse effects have been reported."

Sign Up for New Brunswick Newsletter
Our newsletter delivers the local news that you can trust.

State Health Commissioner Judy Persichilli also tried to alleviate fears during the press briefing.

"It's important to remember that your risk of getting seriously ill or dying from COVID-19 is much greater than experiencing this extremely rare side effect that prompted the federal government, out of an abundance of caution, to pause J&J administration and take time to analyze the data," she said.

"CDC reported that these blood clots in women 18-48 with low blood platelet levels. In New Jersey, 47,266 women have received the J&J vaccine, but again we have no similar reports," Persichilli added. 

Vaccinations Statewide

  • Total Vaccine Doses Administered: 5,641,115
  • People with at least one vaccine dose: 3,589,123, Fully vaccinated people: 2,292,316
  • Asian: 9%, Black: 6%, Hispanic/Latinx: 9%, White: 57%, Other: 10%, Unknown: 9%
  • 16-17: 0%, 18-29: 9%, 30-49: 25%, 50-64: 29%, 65-79: 28%, 80+: 10%
  • Female: 56%, Male: 44%
  • Moderna doses: 44%, Pfizer doses: 52%, J&J doses: 4%

Middlesex County Vaccinations

  • Total Vaccine Doses Administered: 489,022
  • People with at least one vaccine dose: 316,380
  • Fully vaccinated people: 190,721
  • Asian: 25%, Black: 4%, Hispanic/Latinx: 8%, White: 43%, Other: 13%, Unknown: 7%
  • 16-17: 0%, 18-29: 9%, 30-49: 25%, 50-64: 29%, 65-79: 28%, 80+: 10%
  • Female: 55%, Male: 45%